Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Patients With Chronic Kidney Disease

NCT04522622 is registered in ClinicalTrials.gov with Ditte Hansen as lead sponsor.

NCT NCT04522622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04522622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Patients With Chronic Kidney Disease
Lead sponsor
Ditte Hansen
Phase
Phase 4
Overall status
Recruiting
Start date
December 15, 2021
Completion date
September 1, 2027
Enrollment
48 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

adynamic bone disease, cardiac disease, chronic kidney disease-mineral and bone disorder, chronic kidney diseases